Real-world data on the use of insulin glargine 300 U/mL in Japanese patients with type 1 diabetes: twelve-month results from a post-marketing surveillance study (X-STAR study)
Keyword(s):
Keyword(s):
2018 ◽
Vol 83
(1)
◽
pp. 201-207
◽
Keyword(s):
2017 ◽
Vol 19
(3)
◽
pp. 189-201
◽
2020 ◽
Vol 21
(6)
◽
pp. 1697-1699
Keyword(s):